R&D Views & Analysis | pharmaphorum

Views & Analysis

Field of burning oil wells, Persian Gulf War

Gulf War Illness: How can disease modelling aid the search f...

Biological systems are hugely complex, with a staggering number of pathways interacting every millisecond. The downstream effects of just one biological change are enormous.

News

Amylyx ALS drug draws criticism over $158,000 price tag

Amylyx Pharmaceuticals’ Relyvrio – a new treatment for amyotrophic lateral sclerosis (ALS) approved by the FDA on Thursday, after review of the data from its phase 2 trial – was the next da

Videos

Health Innovators – Dr. Houda Hachad

Dr.

Views & Analysis

Lilly’s Mounjaro wins latest head-to-head battle in clinical...

Diabetes is one of the most common health conditions in the United States, afflicting more than 11% of the population, with over 90% included in the type 2 category.

Patients

How a once-weekly insulin could disrupt diabetes management ...

Insulin has been used to manage diabetes for a century, and while many advances have been made for people with both type 1 and type 2 diabetes – many more continue to be made.

R&D

Reconfiguring COVID and influenza vaccines for long-term eff...

Alexandre Le Vert, CEO and co-founder of Osivax, discusses the company's breakthrough vaccine technology, oligoDOM, and how it's driving the development of new influenza and SARS-CoV-2 vacc

Gulf War Illness: How can disease modelling aid the search f...

Amylyx ALS drug draws criticism over $158,000 price tag

Health Innovators – Dr. Houda Hachad

Lilly’s Mounjaro wins latest head-to-head battle in clinical...

How a once-weekly insulin could disrupt diabetes management ...

Reconfiguring COVID and influenza vaccines for long-term eff...

Aspen, Bambusa close IPOs as Corxel takes SPAC route

Discover a new era of healthcare panel engagement: Grounded ...

Views & Analysis

Editor's Picks